OBJECTIVE: Obesity trends in the Western world parallel the increased incidence of adenocarcinoma of the esophagus and esophagogastric junction. The implications of obesity on standard outcomes in the management of localized adenocarcinoma, particularly operative risks, have not been systematically addressed. METHODS: This retrospective analysis of prospectively collected data included 150 consecutive patients (36 [24%] obese [body mass index > 30] and 114 nonobese), of whom 43 were normal weight (body mass index 20-25) and 71 were overweight (body mass index 25-30). Eighty-one patients underwent multimodal therapy. The primary end points were in-hospital mortality and morbidity, and median and overall survivals. RESULTS: Thirty of 36 obese patients (84%) had a body mass index from 30 to 35. Compared with those of the nonobese cohort, obese patients had significantly increased respiratory complications (P = .037), perioperative blood transfusions (P = .021), anastomotic leaks (P = .009), and length of stay (P = .001), but no difference in mortality (P = .582) or major respiratory complications (P = .171). Median and overall survivals were equivalent (P = .348) in both groups. CONCLUSIONS: Obesity was associated with increased respiratory complications and anastomotic leak rates but not with major respiratory complications, mortality, or survival. These outcomes suggest that the added risks of obesity on standard outcomes in esophageal cancer surgery are modest and should not independently have a significant impact on risk assessment in esophageal cancer management.
OBJECTIVE:Obesity trends in the Western world parallel the increased incidence of adenocarcinoma of the esophagus and esophagogastric junction. The implications of obesity on standard outcomes in the management of localized adenocarcinoma, particularly operative risks, have not been systematically addressed. METHODS: This retrospective analysis of prospectively collected data included 150 consecutive patients (36 [24%] obese [body mass index > 30] and 114 nonobese), of whom 43 were normal weight (body mass index 20-25) and 71 were overweight (body mass index 25-30). Eighty-one patients underwent multimodal therapy. The primary end points were in-hospital mortality and morbidity, and median and overall survivals. RESULTS: Thirty of 36 obesepatients (84%) had a body mass index from 30 to 35. Compared with those of the nonobese cohort, obesepatients had significantly increased respiratory complications (P = .037), perioperative blood transfusions (P = .021), anastomotic leaks (P = .009), and length of stay (P = .001), but no difference in mortality (P = .582) or major respiratory complications (P = .171). Median and overall survivals were equivalent (P = .348) in both groups. CONCLUSIONS:Obesity was associated with increased respiratory complications and anastomotic leak rates but not with major respiratory complications, mortality, or survival. These outcomes suggest that the added risks of obesity on standard outcomes in esophageal cancer surgery are modest and should not independently have a significant impact on risk assessment in esophageal cancer management.
Authors: J Wang; B Myles; C Wei; J Y Chang; W L Hofstetter; J A Ajani; S G Swisher; J D Cox; R Komaki; Z Liao; S H Lin Journal: Dis Esophagus Date: 2013-04-26 Impact factor: 3.429
Authors: Ravi Shridhar; Thomas Hayman; Sarah E Hoffe; Jill Weber; Khaldoun Almhanna; Michael Chuong; Richard C Karl; Kenneth L Meredith Journal: J Gastrointest Surg Date: 2012-03-08 Impact factor: 3.452
Authors: Surya Say Biere; Mark I van Berge Henegouwen; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Donald L van der Peet; Miguel A Cuesta Journal: J Thorac Dis Date: 2017-07 Impact factor: 2.895
Authors: Marcovalerio Melis; Jill M Weber; James M McLoughlin; Erin M Siegel; Sarah Hoffe; Ravi Shridhar; Kiran K Turaga; George Dittrick; E Michelle Dean; Richard C Karl; Kenneth L Meredith Journal: Ann Surg Oncol Date: 2010-09-24 Impact factor: 5.344
Authors: Ross F Goldberg; Steven P Bowers; Michael Parker; John A Stauffer; Horacio J Asbun; C Daniel Smith Journal: Surg Endosc Date: 2012-08-31 Impact factor: 4.584